Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression

Psilocybin assisted psychotherapy shows promise for treating depression, a leading cause of disability worldwide. A recent study by Rosenblat et al. reports promising results for using psilocybin in clinical mental health care, particularly for cases where traditional treatments have been insufficient.

Study at a glance

Abstract

Depression is a global public health challenge that represents the world's largest cause of disability, especially in the context of traditional treatments. One potential solution being explored is psilocybin assisted psychotherapy (PAP) which shows promise for treating depression. A recent study by Rosenblat et al. explores the use of psilocybin in clinical mental care with promising results (1).